Research Support

We promote research by offering comprehensive support in the management and implementation of clinical studies.

We provide advice, solutions and structures that accompany the investigator throughout the clinical study process, from design to execution, guaranteeing compliance with all ethical and regulatory standards and ensuring the quality and validity of the research.

Test tubes in a lab tray

Process

  • Design

    The research team, through observation, formulates a research question and idea.

    Research team
  • Approval

    In this phase, it is necessary to prepare the documentation, select the study personnel, obtain the necessary approvals (Ethics Committee, Autonomous Communities, and regulatory agencies), and finally, sign the contracts and register the study on the corresponding platforms.

    CRO - Contract Research Organization
  • CTU team working in the office

    Implementation

    In this phase, all study documents are created (investigator’s file, recruitment materials, among others), and the data collection notebook is developed. Logistic and coordination tasks are carried out to implement the study. Finally, the initiation visit is conducted, during which all key points of the project are reviewed.

    CRO - Contract Research Organization
    CTU - Clinical Trials Unit
  • Manipulationg lab test tube

    Development

    The search and selection of participants are carried out. Study procedures are performed (obtaining informed consent, scheduling study visits, and conducting and tracking procedures). The study is monitored to ensure compliance with regulations and adherence to the research protocol. After its conclusion, the closing visit is conducted.

    CRO - Contract Research Organization
    CTU - Clinical Trials Unit
  • Analysis

    Data exports are carried out for analysis purposes. These are interpreted in order to address the hypotheses and objectives outlined in the protocol’s design. Finally, the results of the questions posed and the conclusions drawn are documented.

    CRO - Contract Research Organization
  • Communication

    Based on the evidence found, the results are published in scientific journals and specialized conferences to enhance the knowledge of the scientific community.

    ScienHub Education

Units

Our success lies in the combined efforts from the CRO and CTU teams that provide thorough support to the research team.

  • CRO

    Contract Research Organization

    We provide advice on all procedures related to the submission, documentation, start-up, development and completion of a clinical study, ensuring compliance with regulations and good clinical practices, as well as the final success of the project.

  • CTU

    Clinical Trials Unit

    Taking blood for analytics

    We handle the implementation of all the procedures of a clinical trial, applying strict compliance with current regulations and guaranteeing the rights, safety and well-being of the participants, as well as the quality and traceability of the data obtained.

Soc Recerca

A platform for recruiting volunteers interested in participating in clinical trials aimed at improving medical research and global health.

Feedback

What do they think of us?

  • The relationship and performance of the entire team were exceptional throughout the trial. Congratulations!”

    Hepatitis Study - External Monitor
    ScienHub Research Support - CTU
  • The service provided by ScienHub Research Support – CRO stands out for its very good and respectful collaboration. We feel like we work together to make everything function in the best way possible. If there is any misunderstanding, we communicate openly, ask questions, and find solutions together, which is highly appreciated.

    External Monitor from Rigshospitalet, University of Copenhagen
    ScienHub Research Support - CRO
  • The team’s work on the study is excellent. The communication with the coordinator is very good, with great availability and responsiveness.

    HIV Study - External Monitor
    ScienHub Research Support - CTU
  • An excellent team—not only for their professionalism but also for their kindness, friendliness, and cooperation with the CRO representatives.

    Nephrology Study - External Monitor
    ScienHub Research Support - CTU
  • The level of satisfaction obtained by different promoters regarding the work carried out by ScienHub Research Support – CTU is 4.84 out of 5.

    Activity Report 2024
    ScienHub Research Support - CTU
  • A truly good service, with close communication between the promoter and the CRO, but also independence in carrying out delegated tasks.

    Júlia Corominas
    Hipra

References

Check out some of the latest projects we’ve worked on.

  • New Hope for Cognitive Decline: LAMIFERON Study Evaluates the Effect of Lamivudine

    A research team led by Fundació Lluita contra les Infeccions and IrsiCaixa, in collaboration with Hospital Universitari Germans Trias i Pujol and the BBRC, is investigating the impact of lamivudine (3TC) on biomarkers associated with mild cognitive impairment (MCI). The study will include 25 participants and will analyze the drug’s effects on type I interferon-stimulated genes.

    To ensure the project’s success, ScienHub Research Support provides full assistance through its CRO and CTU, ensuring protocol compliance and good clinical practices. Additionally, the study will serve to evaluate

  • Thalassa 2.0: Investigating Plitidepsin’s Potential Against Long COVID

    The Fundació Lluita contra les Infeccions and PharmaMar launched the Thalassa 2.0 trial, a phase II study aimed at evaluating the effectiveness of plitidepsin in treating long COVID. The study seeks to provide new therapeutic options for patients.

    ScienHub Research Support is in charge of the study’s planning, execution and monitoring reinforcing its commitment to innovative treatments. Its intense involvement highlights its key role and commitment in advancing potential therapies for long COVID and strengthening its presence in supporting medical research.

  • BCN03 Trial: Advancing Therapeutic Vaccines for HIV Control

    The BCN03 clinical trial, a phase I study led by IrsiCaixa, is a randomized, double-blind, placebo-controlled study involving 30 participants. It aims to evaluate the safety, tolerability, and immunogenicity of therapeutic vaccines against HIV-1 (ChAdOx1.HTI, MVA.HTI, and ConM SOSIP.v7 gp140) to develop immune-based strategies for controlling the virus without lifelong treatment.

    The ScienHub Research Support team (CTU/CRO) managed the trial’s procedures, regulatory processes, and study monitoring, providing full support to the research team throughout all phases—from initiation to completion.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop